The Higher Regional Court of Vienna confirmed that the “second medical use” of an already known substance, as required for patent protection, can be that the substance is used for a specific group of patients with specific effects.

Case date: 11 May 2017
Case number: 34R113/16m
Court: Higher Regional Court of Vienna

A full summary of this case has been published on Kluwer IP Law.



Kluwer IP Law
This page as PDF